吳繼紅，女，畢業於江西師範大學，副教授，碩士生導師。
人物經歷,研究方向,主要貢獻,
人物經歷
吳繼紅，物理化學研究所，2000年江西師範大學本套多科樂漏整斷畢業，2003年廈門大學固體表面物理化學國家重點實驗室碩士學位，2009年嚷櫻射新加坡國立大學化學系博士學位， 2009-2011 新加坡國立大學化學系博士後。
2011年9月加入蘇州大學材料與化學化工學部，副教授燥盼判。
研究方向
納米材料的製備與自組裝，金屬及半導體納米材料的表面電漿共振，電漿耦合效探笑府應，激子-電漿耦合，表面等離子拉曼散射增強和螢光增強，陵臘艱迎離子背蒸格體器件。
主要貢獻
1. Ji Hong Wu, Zhenping Guan, Tian Ze Xu, Qing-Hua Xu*, and Guo Qin Xu* Tetracene-Doped Anthracene Nanowire Arrays: Preparation and Doping Effects.Langmuir2011,27, 6374-6380.
2.Ji Hong Wu, Tian Ze Xu, Siau Gek Ang, Qing-Hua Xu*, and Guo Qin Xu* Radially oriented anthracene nanowire arrays: preparation, growth mechanism, and optical fluorescence.Nanoscale2011,3, 1855-1860.
3.Ji Hong Wu, Binni Varghese, Xue Dong Zhou, Si Ying Teo, Chorng Haur Sow, Siau Gek Ang, and Guo Qin Xu* Interconnected Networks of Porous Zinc Oxide Multi-walled Nanotubes.Chemistry of Materials2010,22, 1533-1539.
4.Ji Hong Wu, Siau Gek Ang, and Guo Qin Xu* Atomic Force Microscopy Study of Self-Assembled Sodium Chloride Nanocrystallites and Their Morphology Transitions.Journal of Physical Chemistry C2008,112, 7605-7610.
(5)Ye N, Neumeyer JL, Baldessarini RJ, Zhen X, Zhang A.Update 1 of: Recent Progress in Development of Dopamine Receptor Subtype-Selective Agents: Potential Therapeutics for Neurological and Psychiatric Disorders. Chem Rev. 2013 Mar 7. [Epub ahead of print].
(6)Haifeng Suna, Liyuan Zhub, Huicui Yangc, Wangke Qiana, Lin Guob, Shengbin Zhoua, Bo Gaoc, Zeng Lia, Yu Zhoua, Hualiang Jianga, Kaixian Chena, Xuechu Zhen, Hong Liu Asymmetric Total Synthesis and Identification of Tetrahydroprotoberberine Derivatives as New Antipsychotic Agents Possessing a Dopamine D1, D2 and Serotonin 5-HT1A Multi-Action Profile. BIOORG. MED. CHEM. ;21(4):856-68
(7)Liu CL, Gao M, Jin GZ, Zhen X. GABA Neurons in the Ventral Tegmental Area Responding to Peripheral Sensory Input. PLoS One. 2012;7(12):e51507. doi: 10.1371.
(8)Qian W, Lu W, Sun H, Li Z, Zhu L, Zhao R, Zhang L, Zhou S, Zhou Y, Jiang H, Zhen X, Liu H. Design, synthesis, and pharmacological evaluation of novel tetrahydroprotoberberine derivatives: selective inhibitors of dopamine D receptor.Bioorg Med Chem. 2012, 20(15):4862-71.
(9)Zheng YY, Guo L, Zhen XC, Li JQ. Synthesis and antidepressant activity of arylalkanol-piperidine derivatives as triple reuptake inhibitors. Eur J Med Chem. 2012, 54:123-36.
(10)Xu Z, Dong S, Du D, Jiang N, Sun P, Wang H, Yin L, Zhang X, Cao X, Zhen X, Hu Y. Generation and characterization of hD(5) and C-terminal Mutant hD(5m) transgenic rats. Brain Res. 2012, 1448:27-41.
(11)Chu HY, Wu Q, Zhou S, Cao X, Zhang A, Jin GZ, Hu GY, Zhen X. SKF83959 suppresses excitatory synaptic transmission in rat hippocampus via a dopamine receptor-independent mechanism. J Neurosci Res. 2011 Aug;89(8):1259-66.
(12)Zhang H, Ye N, Zhou S, Guo L, Zheng L, Liu Z, Gao B, Zhen X, Zhang A. Identification of N-Propylnoraporphin-11-yl 5-(1,2-Dithiolan-3-yl)pentanoate as a New Anti-Parkinson's Agent Possessing a Dopamine D(2) and Serotonin 5-HT(1A) Dual-Agonist Profile. J Med Chem. 2011 Jun 14. 54(13):4324-38.
(13)Ye N, Wu Q, Zhu L, Zheng L, Gao B, Zhen X, Zhang A. Further SAR study on 11-O-substituted aporphine analogues: Identification of highly potent dopamine D(3) receptor ligands. Bioorg Med Chem. 2011 Mar 15; 19(6):1999-2008.
(14)Chu HY, Yang Z, Zhao B, Jin GZ, Hu GY, Zhen X*. Activation of phosphatidylinositol-linked D1-like receptors increases spontaneous glutamate release in rat somatosensory cortical neurons in vitro. Brain Res. 2010 Jul 9; 1343:20-7.
(15)Mo J, Zhang H, Yu LP, Sun PH, Jin GZ, Zhen X. L-stepholidine reduced L-DOPA-induced dyskinesia in 6-OHDA-lesioned rat model of Parkinson's disease. Neurobiol Aging. 2010 Jun; 31(6):926-36.
(7)Liu CL, Gao M, Jin GZ, Zhen X. GABA Neurons in the Ventral Tegmental Area Responding to Peripheral Sensory Input. PLoS One. 2012;7(12):e51507. doi: 10.1371.
(8)Qian W, Lu W, Sun H, Li Z, Zhu L, Zhao R, Zhang L, Zhou S, Zhou Y, Jiang H, Zhen X, Liu H. Design, synthesis, and pharmacological evaluation of novel tetrahydroprotoberberine derivatives: selective inhibitors of dopamine D receptor.Bioorg Med Chem. 2012, 20(15):4862-71.
(9)Zheng YY, Guo L, Zhen XC, Li JQ. Synthesis and antidepressant activity of arylalkanol-piperidine derivatives as triple reuptake inhibitors. Eur J Med Chem. 2012, 54:123-36.
(10)Xu Z, Dong S, Du D, Jiang N, Sun P, Wang H, Yin L, Zhang X, Cao X, Zhen X, Hu Y. Generation and characterization of hD(5) and C-terminal Mutant hD(5m) transgenic rats. Brain Res. 2012, 1448:27-41.
(11)Chu HY, Wu Q, Zhou S, Cao X, Zhang A, Jin GZ, Hu GY, Zhen X. SKF83959 suppresses excitatory synaptic transmission in rat hippocampus via a dopamine receptor-independent mechanism. J Neurosci Res. 2011 Aug;89(8):1259-66.
(12)Zhang H, Ye N, Zhou S, Guo L, Zheng L, Liu Z, Gao B, Zhen X, Zhang A. Identification of N-Propylnoraporphin-11-yl 5-(1,2-Dithiolan-3-yl)pentanoate as a New Anti-Parkinson's Agent Possessing a Dopamine D(2) and Serotonin 5-HT(1A) Dual-Agonist Profile. J Med Chem. 2011 Jun 14. 54(13):4324-38.
(13)Ye N, Wu Q, Zhu L, Zheng L, Gao B, Zhen X, Zhang A. Further SAR study on 11-O-substituted aporphine analogues: Identification of highly potent dopamine D(3) receptor ligands. Bioorg Med Chem. 2011 Mar 15; 19(6):1999-2008.
(14)Chu HY, Yang Z, Zhao B, Jin GZ, Hu GY, Zhen X*. Activation of phosphatidylinositol-linked D1-like receptors increases spontaneous glutamate release in rat somatosensory cortical neurons in vitro. Brain Res. 2010 Jul 9; 1343:20-7.
(15)Mo J, Zhang H, Yu LP, Sun PH, Jin GZ, Zhen X. L-stepholidine reduced L-DOPA-induced dyskinesia in 6-OHDA-lesioned rat model of Parkinson's disease. Neurobiol Aging. 2010 Jun; 31(6):926-36.
